Skip to main content
Log in

Adipokine levels in overweight women with early-onset gestational diabetes mellitus

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Purpose

The study of adipokines in overweight women with early-onset (diagnosed before 20 weeks) gestational diabetes mellitus (GDM) could help to understand the ethiopathological mechanisms of this disorder. Our aim was to assess adipokine levels in overweight pregnant women with early-onset GDM compared to patients with standard-onset (diagnosed at 24–28 weeks) GDM and to glucose-tolerant women at the same gestational ages.

Methods

This nested case–control study included 133 overweight pregnant women: 33 with early-onset (diagnosed < 20 weeks) GDM; 40 with standard-onset (diagnosed ≥ 24 weeks) GDM and 60 glucose-tolerant (normal oral glucose tolerance tests < 20 and ≥ 24 weeks). Adiponectin, leptin, resistin, visfatin and ghrelin serum levels were measured by ELISA.

Results

Adiponectin serum levels were significantly lower in early-onset GDM women than in standard-onset GDM patients or controls matched for gestational age. Leptin serum levels were significantly higher in women with early-onset GDM than in controls. Women with early-onset GDM had lower adiponectin/leptin ratio than those with standard-onset GDM. There were no significant differences in resistin, ghrelin and visfatin serum levels among the participants.

Conclusions

Our results suggest that, compared to overweight glucose-tolerant women and patients with standard-onset GDM, overweight women with early-onset GDM have unbalanced adipokine levels, suggesting that they have a more inflammatory profile.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Torloni MR, Betran AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, Valente O (2009) Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev 10(2):194–203. https://doi.org/10.1111/j.1467-789X.2008.00541.x

    Article  CAS  PubMed  Google Scholar 

  2. Yuen L, Wong VW (2015) Gestational diabetes mellitus: challenges for different ethnic groups. World J Diabetes 6(8):1024–1032. https://doi.org/10.4239/wjd.v6.i8.1024

    Article  PubMed  PubMed Central  Google Scholar 

  3. Gandhi P, Farrell T (2011) Gestational diabetes mellitus (GDM) screening in morbidly obese pregnant women. Eur J Obstet Gynecol Reprod Biol 159(2):329–332. https://doi.org/10.1016/j.ejogrb.2011.09.015

    Article  PubMed  Google Scholar 

  4. Immanuel J, Simmons D (2017) Screening and treatment for early-onset gestational diabetes mellitus: a systematic review and meta-analysis. Curr Diabetes Rep 17(11):115. https://doi.org/10.1007/s11892-017-0943-7

    Article  Google Scholar 

  5. WHO (2014) Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res Clin Pract 103(3):341–363

    Article  Google Scholar 

  6. Sweeting AN, Ross GP, Hyett J, Molyneaux L, Constantino M, Harding AJ, Wong J (2016) Gestational diabetes mellitus in early pregnancy: evidence for poor pregnancy outcomes despite treatment. Diabetes Care 39(1):75–81. https://doi.org/10.2337/dc15-0433

    Article  CAS  PubMed  Google Scholar 

  7. Briana DD, Malamitsi-Puchner A (2009) Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci 16(10):921–937. https://doi.org/10.1177/1933719109336614

    Article  CAS  PubMed  Google Scholar 

  8. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17(1):4–12

    CAS  PubMed  Google Scholar 

  9. Behboudi-Gandevani S, Ramezani Tehrani F, Bidhendi Yarandi R, Noroozzadeh M, Hedayati M, Azizi F (2017) The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines. J Endocrinol Investig 40(8):859–866. https://doi.org/10.1007/s40618-017-0650-x

    Article  CAS  Google Scholar 

  10. Marques-Vidal P, Bochud M, Paccaud F, Mooser V, Waeber G, Vollenweider P (2010) Distribution of plasma levels of adiponectin and leptin in an adult Caucasian population. Clin Endocrinol (Oxf) 72(1):38–46. https://doi.org/10.1111/j.1365-2265.2009.03628.x

    Article  CAS  Google Scholar 

  11. Gharibeh MY, Al Tawallbeh GM, Abboud MM, Radaideh A, Alhader AA, Khabour OF (2010) Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients. Diabetes Metab 36(6 Pt 1):443–449. https://doi.org/10.1016/j.diabet.2010.05.003

    Article  CAS  PubMed  Google Scholar 

  12. Yadav A, Kataria MA, Saini V, Yadav A (2013) Role of leptin and adiponectin in insulin resistance. Clin Chim Acta 417:80–84. https://doi.org/10.1016/j.cca.2012.12.007

    Article  CAS  PubMed  Google Scholar 

  13. Lee YH, Magkos F, Mantzoros CS, Kang ES (2011) Effects of leptin and adiponectin on pancreatic beta-cell function. Metabolism 60(12):1664–1672. https://doi.org/10.1016/j.metabol.2011.04.008

    Article  CAS  PubMed  Google Scholar 

  14. Schwartz DR, Lazar MA (2011) Human resistin: found in translation from mouse to man. Trends Endocrinol Metab 22(7):259–265. https://doi.org/10.1016/j.tem.2011.03.005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Vrachnis N, Belitsos P, Sifakis S, Dafopoulos K, Siristatidis C, Pappa KI, Iliodromiti Z (2012) Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus. Int J Endocrinol 2012:549748. https://doi.org/10.1155/2012/549748

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Amini P, Wadden D, Cahill F, Randell E, Vasdev S, Chen X, Gulliver W, Zhang W, Zhang H, Yi Y, Sun G (2012) Serum acylated ghrelin is negatively correlated with the insulin resistance in the CODING study. PLoS One 7(9):e45657. https://doi.org/10.1371/journal.pone.0045657

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Chang YH, Chang DM, Lin KC, Shin SJ, Lee YJ (2011) Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review. Diabetes Metab Res Rev 27(6):515–527. https://doi.org/10.1002/dmrr.1201

    Article  CAS  PubMed  Google Scholar 

  18. McGee KC, Harte AL, da Silva NF, Al-Daghri N, Creely SJ, Kusminski CM, Tripathi G, Levick PL, Khanolkar M, Evans M, Chittari MV, Patel V, Kumar S, McTernan PG (2011) Visfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NFkappaB and JNK in human abdominal subcutaneous adipocytes. PLoS One 6(6):e20287. https://doi.org/10.1371/journal.pone.0020287

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Guelfi KJ, Ong MJ, Li S, Wallman KE, Doherty DA, Fournier PA, Newnham JP, Keelan JA (2017) Maternal circulating adipokine profile and insulin resistance in women at high risk of developing gestational diabetes mellitus. Metabolism 75:54–60. https://doi.org/10.1016/j.metabol.2017.08.003

    Article  CAS  PubMed  Google Scholar 

  20. Lain KY, Daftary AR, Ness RB, Roberts JM (2008) First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol (Oxf) 69(3):407–411. https://doi.org/10.1111/j.1365-2265.2008.03198.x

    Article  Google Scholar 

  21. Kautzky-Willer A, Pacini G, Tura A, Bieglmayer C, Schneider B, Ludvik B, Prager R, Waldhausl W (2001) Increased plasma leptin in gestational diabetes. Diabetologia 44(2):164–172. https://doi.org/10.1007/s001250051595

    Article  CAS  PubMed  Google Scholar 

  22. Chen D, Fang Q, Chai Y, Wang H, Huang H, Dong M (2007) Serum resistin in gestational diabetes mellitus and early postpartum. Clin Endocrinol (Oxf) 67(2):208–211. https://doi.org/10.1111/j.1365-2265.2007.02862.x

    Article  CAS  Google Scholar 

  23. Lopez-Tinoco C, Roca M, Fernandez-Deudero A, Garcia-Valero A, Bugatto F, Aguilar-Diosdado M, Bartha JL (2012) Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus. Cytokine 58(1):14–19. https://doi.org/10.1016/j.cyto.2011.12.004

    Article  CAS  Google Scholar 

  24. Cortelazzi D, Corbetta S, Ronzoni S, Pelle F, Marconi A, Cozzi V, Cetin I, Cortelazzi R, Beck-Peccoz P, Spada A (2007) Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf) 66(3):447–453. https://doi.org/10.1111/j.1365-2265.2007.02761.x

    Article  CAS  Google Scholar 

  25. Skvarca A, Tomazic M, Krhin B, Blagus R, Janez A (2012) Adipocytokines and insulin resistance across various degrees of glucose tolerance in pregnancy. J Int Med Res 40(2):583–589. https://doi.org/10.1177/147323001204000220

    Article  CAS  PubMed  Google Scholar 

  26. Rezvan N, Hosseinzadeh-Attar MJ, Masoudkabir F, Moini A, Janani L, Mazaherioun M (2012) Serum visfatin concentrations in gestational diabetes mellitus and normal pregnancy. Arch Gynecol Obstet 285(5):1257–1262. https://doi.org/10.1007/s00404-011-2156-7

    Article  CAS  PubMed  Google Scholar 

  27. Ma Y, Cheng Y, Wang J, Cheng H, Zhou S, Li X (2010) The changes of visfatin in serum and its expression in fat and placental tissue in pregnant women with gestational diabetes. Diabetes Res Clin Pract 90(1):60–65. https://doi.org/10.1016/j.diabres.2010.06.010

    Article  CAS  PubMed  Google Scholar 

  28. Tham E, Liu J, Innis S, Thompson D, Gaylinn BD, Bogarin R, Haim A, Thorner MO, Chanoine JP (2009) Acylated ghrelin concentrations are markedly decreased during pregnancy in mothers with and without gestational diabetes: relationship with cholinesterase. Am J Physiol Endocrinol Metab 296(5):E1093–E1100. https://doi.org/10.1152/ajpendo.90866.2008

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Genser B, Cooper PJ, Yazdanbakhsh M, Barreto ML, Rodrigues LC (2007) A guide to modern statistical analysis of immunological data. BMC Immunol 8:27. https://doi.org/10.1186/1471-2172-8-27

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Cammu H, Dony N, Martens G, Colman R (2014) Common determinants of breech presentation at birth in singletons: a population-based study. Eur J Obstet Gynecol Reprod Biol 177:106–109. https://doi.org/10.1016/j.ejogrb.2014.04.008

    Article  PubMed  Google Scholar 

  31. Thagaard IN, Krebs L, Holm JC, Lange T, Larsen T, Christiansen M (2017) Adiponectin and leptin as first trimester markers for gestational diabetes mellitus: a cohort study. Clin Chem Lab Med 55(11):1805–1812. https://doi.org/10.1515/cclm-2017-0427

    Article  CAS  PubMed  Google Scholar 

  32. Maitland RA, Seed PT, Briley AL, Homsy M, Thomas S, Pasupathy D, Robson SC, Nelson SM, Sattar N, Poston L, consortium Ut (2014) Prediction of gestational diabetes in obese pregnant women from the UK Pregnancies Better Eating and Activity (UPBEAT) pilot trial. Diabet Med 31(8):963–970. https://doi.org/10.1111/dme.12482

    Article  CAS  PubMed  Google Scholar 

  33. Bhograj A, Suryanarayana KM, Nayak A, Murthy NS, Dharmalingam M, Kalra P (2016) Serum adiponectin levels in gestational diabetes mellitus. Indian J Endocrinol Metab 20(6):752–755. https://doi.org/10.4103/2230-8210.192909

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Pala HG, Ozalp Y, Yener AS, Gerceklioglu G, Uysal S, Onvural A (2015) Adiponectin levels in gestational diabetes mellitus and in pregnant women without glucose intolerance. Adv Clin Exp Med 24(1):85–92. https://doi.org/10.17219/acem/38141

    Article  PubMed  Google Scholar 

  35. Zavalza-Gomez AB, Anaya-Prado R, Rincon-Sanchez AR, Mora-Martinez JM (2008) Adipokines and insulin resistance during pregnancy. Diabetes Res Clin Pract 80(1):8–15. https://doi.org/10.1016/j.diabres.2007.12.012

    Article  CAS  PubMed  Google Scholar 

  36. Pendeloski KPT, Ono E, Torloni MR, Mattar R, Daher S (2017) Maternal obesity and inflammatory mediators: a controversial association. Am J Reprod Immunol. https://doi.org/10.1111/aji.12674

    Article  PubMed  Google Scholar 

  37. Gao XL, Yang HX, Zhao Y (2008) Variations of tumor necrosis factor-alpha, leptin and adiponectin in mid-trimester of gestational diabetes mellitus. Chin Med J (Engl) 121(8):701–705

    Article  CAS  Google Scholar 

  38. Maple-Brown L, Ye C, Hanley AJ, Connelly PW, Sermer M, Zinman B, Retnakaran R (2012) Maternal pregravid weight is the primary determinant of serum leptin and its metabolic associations in pregnancy, irrespective of gestational glucose tolerance status. J Clin Endocrinol Metab 97(11):4148–4155. https://doi.org/10.1210/jc.2012-2290

    Article  CAS  PubMed  Google Scholar 

  39. Prentice AM, Jebb SA (2001) Beyond body mass index. Obes Rev 2(3):141–147

    Article  CAS  PubMed  Google Scholar 

  40. Ballesteros M, Simon I, Vendrell J, Ceperuelo-Mallafre V, Miralles RM, Albaiges G, Tinahones F, Megia A (2011) Maternal and cord blood adiponectin multimeric forms in gestational diabetes mellitus: a prospective analysis. Diabetes Care 34(11):2418–2423. https://doi.org/10.2337/dc11-0788

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Matuszek B, Burska A, Leszczynska-Gorzelak B, Donica H, Nowakowski A (2013) Comparative analysis of adiponectin isoform distribution in pregnant women with gestational diabetes mellitus and after delivery. Acta Obstet Gynecol Scand 92(8):951–959. https://doi.org/10.1111/aogs.12137

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2010-52547-5; 2011-14620-5) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq 475500/2011-3).

Funding

This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2010-52547-5; 2011-14620-5) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq 475500/2011-3).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Daher.

Ethics declarations

Conflict of interest

All the authors declare that there is no conflict of interest.

Ethical approval

The research protocol was approved by the university’s ethics committee.

Human and animal rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards

Informed consent

Written informed consent was obtained from all participants.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lobo, T.F., Torloni, M.R., Mattar, R. et al. Adipokine levels in overweight women with early-onset gestational diabetes mellitus. J Endocrinol Invest 42, 149–156 (2019). https://doi.org/10.1007/s40618-018-0894-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-018-0894-0

Keywords

Navigation